A new London-Japan partnership to understand why devastating neurodegenerative diseases such as Parkinson’s or Motor Neurone Disease develop and how they can be disrupted will be announced today by the Mayor of London Boris Johnson during his trade mission to Japan.
The new partnership between Takeda Pharmaceutical Company Limited (TSE: 4502), Japan’s largest pharmaceutical company,
No comments:
Post a Comment